Razeghian E, Kameh M, Shafiee S, Khalafi F, Jafari F, Asghari M
Mol Biol Rep. 2022; 49(11):10935-10948.
PMID: 36008609
DOI: 10.1007/s11033-022-07865-5.
He X, Zeng X
Drug Des Devel Ther. 2022; 16:951-972.
PMID: 35386853
PMC: 8979261.
DOI: 10.2147/DDDT.S347297.
Lu T, Ma R, Li Z, Mansour A, Teng K, Chen L
Cancer Immunol Res. 2021; 9(10):1229-1241.
PMID: 34326137
PMC: 8562593.
DOI: 10.1158/2326-6066.CIR-20-1014.
Oh E, Min B, Li Y, Lian C, Hong J, Park G
Cancers (Basel). 2019; 11(7).
PMID: 31324057
PMC: 6678894.
DOI: 10.3390/cancers11070966.
Wilton K, Billadeau D
J Immunol. 2018; 201(10):2899-2909.
PMID: 30282752
PMC: 6317751.
DOI: 10.4049/jimmunol.1800254.
Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases.
Konishi H, Kiyama H
Front Cell Neurosci. 2018; 12:206.
PMID: 30127720
PMC: 6087757.
DOI: 10.3389/fncel.2018.00206.
Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway.
Wang Y, Qin X, Zhu X, Chen W, Zhang J, Chen W
Oral Oncol. 2018; 76:34-41.
PMID: 29290284
PMC: 11849059.
DOI: 10.1016/j.oraloncology.2017.11.024.
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
Liu D, Tian S, Zhang K, Xiong W, Lubaki N, Chen Z
Protein Cell. 2017; 8(12):861-877.
PMID: 28488245
PMC: 5712291.
DOI: 10.1007/s13238-017-0415-5.
KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.
Morales-Estevez C, de la Haba-Rodriguez J, Manzanares-Martin B, Porras-Quintela I, Rodriguez-Ariza A, Moreno-Vega A
Front Immunol. 2016; 7:561.
PMID: 27994592
PMC: 5136734.
DOI: 10.3389/fimmu.2016.00561.
[Study of the effect of natural killer cells kill dendritic cells by blockade of CD158 receptor epitipe].
Wang X, Guan T, Wang J, Zhao J, Ma L, Su L
Zhonghua Xue Ye Xue Za Zhi. 2016; 37(3):248-50.
PMID: 27033767
PMC: 7342939.
DOI: 10.3760/cma.j.issn.0253-2727.2016.03.016.
Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type Receptors.
Fei C, Pemberton J, Lillico D, Zwozdesky M, Stafford J
Biology (Basel). 2016; 5(1).
PMID: 27005670
PMC: 4810170.
DOI: 10.3390/biology5010013.
TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M, Diaz-Rodriguez Y, Cordeau M, Cordeiro P, Haddad E, Herblot S
Oncotarget. 2015; 6(30):29440-55.
PMID: 26320191
PMC: 4745738.
DOI: 10.18632/oncotarget.4984.
High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
Bayigga L, Nabatanzi R, Sekiziyivu P, Mayanja-Kizza H, Kamya M, Kambugu A
BMC Immunol. 2014; 15:2.
PMID: 24483185
PMC: 3915033.
DOI: 10.1186/1471-2172-15-2.
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.
Zhang H, Cui Y, Voong N, Sabatino M, Stroncek D, Morisot S
J Immunother. 2011; 34(2):187-95.
PMID: 21304401
PMC: 3128544.
DOI: 10.1097/CJI.0b013e31820d2a21.
Natural killer cell immunotherapy for cancer: a new hope.
Srivastava S, Lundqvist A, Childs R
Cytotherapy. 2008; 10(8):775-83.
PMID: 19089686
PMC: 7213758.
DOI: 10.1080/14653240802648181.
Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.
Binyamin L, Alpaugh R, Hughes T, Lutz C, Campbell K, Weiner L
J Immunol. 2008; 180(9):6392-401.
PMID: 18424763
PMC: 2810560.
DOI: 10.4049/jimmunol.180.9.6392.
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.
Epling-Burnette P, Bai F, Painter J, Rollison D, Salih H, Krusch M
Blood. 2007; 109(11):4816-24.
PMID: 17341666
PMC: 1885518.
DOI: 10.1182/blood-2006-07-035519.
Effect of 70-kDa heat shock protein on interferon-gamma production by human natural killers.
Kovalenko E, Vlaskin P, Kanevskii L, Strelnikova Y, Sapozhnikov A
Dokl Biol Sci. 2006; 406:4-6.
PMID: 16572800
DOI: 10.1134/s0012496606010029.
Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.
Solana R, G Casado J, Delgado E, DelaRosa O, Marin J, Duran E
Cancer Immunol Immunother. 2006; 56(1):101-9.
PMID: 16485126
PMC: 11030256.
DOI: 10.1007/s00262-006-0141-y.
Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity.
Addison E, North J, Bakhsh I, Marden C, Haq S, Al-Sarraj S
Immunology. 2005; 116(3):354-61.
PMID: 16236125
PMC: 1802415.
DOI: 10.1111/j.1365-2567.2005.02235.x.